{"id":"W2972627544","doi":"10.1002/ajh.25637","title":"Rifaximin for sickle cell disease","year":2019,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bausch Health","keywords":"Rifaximin; Medicine; Disease; Internal medicine; Intensive care medicine; Biology; Antibiotics; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001516026,0.0002956285,0.001517992,0.0003098356,0.00003951149,0.000009283261,0.0002270037,0.0003670023,0.0001248651],"category_scores_gemma":[0.0001561483,0.0002177879,0.0006593324,0.0001451712,0.0003679913,0.00003364291,0.00002900398,0.001672663,0.00008435733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000583764,"about_ca_system_score_gemma":0.0006950065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001010087,"about_ca_topic_score_gemma":2.157344e-7,"domain_scores_codex":[0.9981761,0.00009186261,0.0007214576,0.0002481615,0.0002829776,0.0004794422],"domain_scores_gemma":[0.9975815,0.0004017082,0.001190079,0.0003558384,0.0002775704,0.0001933334],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005372887,0.0001114193,0.0008042798,0.000711119,0.0002529836,0.002792498,0.00007890613,0.000004983766,0.00003152032,0.0000221485,0.9926873,0.001965546],"study_design_scores_gemma":[0.002072791,0.002261054,0.0000588835,0.0003431172,0.0009456138,0.003501748,0.0002996583,0.00002772302,0.0001150457,0.0001719724,0.9899527,0.0002497105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.02232399,0.004807045,0.0007460085,0.9684836,0.001519488,0.0006051707,0.00004637115,0.00002188732,0.001446409],"genre_scores_gemma":[0.04337553,0.0007797856,0.002511167,0.9452262,0.002611982,0.00001727578,0.000126995,0.0001667665,0.005184324],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.02325746,"threshold_uncertainty_score":0.8881134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007621559220972164,"score_gpt":0.2486370862614922,"score_spread":0.24101552704052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}